HRT Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

HRT Financial’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Buy	+23,870	New	+$369K	﹤0.01%	2807
2025 Q2	–	Sell	-127,998	Closed	-$453K	–	2544
2025 Q1	$453K	Buy	+127,998	New	+$456K	﹤0.01%	1519
2024 Q4	–	Sell	-81,291	Closed	-$263K	–	2385
2024 Q3	$263K	Buy	81,291 +51,748	+175%	+$116K	﹤0.01%	1857
2024 Q2	$56K	Buy	+29,543	New	+$57.3K	﹤0.01%	1821
2024 Q1	–	Sell	-42,192	Closed	-$621K	–	2258
2023 Q4	$621K	Buy	42,192 +16,098	+62%	+$247K	﹤0.01%	1248
2023 Q3	$477K	Sell	26,094 -23,112	-47%	-$489K	﹤0.01%	1427
2023 Q2	$1.06M	Sell	49,206 -44,584	-48%	-$1.2M	0.01%	918
2023 Q1	$2.75M	Buy	+93,790	New	+$3.26M	0.03%	457

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

HRT Financial's AMLX Position: Q2 2026 in Review

HRT Financial opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 23,870 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings. This is a return to the name: HRT Financial previously reported a position in AMLX as recently as Q1 2025.

HRT Financial first reported a position in AMLX in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.75M in Q1 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

HRT Financial held 23,870 shares of Amylyx Pharmaceuticals worth $428K as of Q2 2026.
Amylyx Pharmaceuticals was a new HRT Financial position in Q2 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2807 holding.
HRT Financial first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
HRT Financial's Amylyx Pharmaceuticals position peaked at $2.75M in Q1 2023.
206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.